Evidence map›Paper›PMID 36128106›Full record

ArticleSurgical neurology international2022

Destructive spondylodiscitis associated with SAPHO syndrome: A case report and literature review.

Shu Takeuchi, Junya Hanakita, Toshiyuki Takahashi, Manabu Minami, Ryo Kanematsu, Izumi Suda, Sho Nakamura

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Surgical neurology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shu TakeuchiSpinal Disorders Center, Fujieda Heisei Memorial Hospital, Mizukami, Fujieda, Japan.
Junya HanakitaSpinal Disorders Center, Fujieda Heisei Memorial Hospital, Mizukami, Fujieda, Japan.
Toshiyuki TakahashiSpinal Disorders Center, Fujieda Heisei Memorial Hospital, Mizukami, Fujieda, Japan.
Manabu MinamiSpinal Disorders Center, Fujieda Heisei Memorial Hospital, Mizukami, Fujieda, Japan.
Ryo KanematsuSpinal Disorders Center, Fujieda Heisei Memorial Hospital, Mizukami, Fujieda, Japan.
Izumi SudaSpinal Disorders Center, Fujieda Heisei Memorial Hospital, Mizukami, Fujieda, Japan.
Sho NakamuraSpinal Disorders Center, Fujieda Heisei Memorial Hospital, Mizukami, Fujieda, Japan.
Fujieda Municipal General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare sterile inflammatory disease characterized by cutaneous and osteoarticular lesions. Associated spinal lesions chronically manifest slight or no neurological symptoms. Only rarely does destructive spondylodiscitis occur. Case Description: A 62-year-old female with palmoplantar pustulosis presented with a rapidly progressive quadriparesis. When the cervical MR showed destructive spondylodiscitis at the C5-C7 level, the patient underwent anterior debridement followed by posterior reconstruction/fixation. The histopathology showed a nonspecific inflammatory process with vertebral sclerosis consistent with the diagnosis of SAPHO; cultures were negative. Postoperatively, the patient's symptoms improved and SAPHO did not recur. Conclusion: Destructive spondylodiscitis associated with SAPHO syndrome is uncommon. Early diagnosis and surgical treatment result in the best outcomes.

Indexed as

Destructive spondylodiscitisSAPHO syndromeSpine surgery

Identifiers

PMID36128106
PMCPMC9479651
OpenAlexW4289878877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.